Yatırımcı.AI

ECILC vs CIMSA Comparison

Price, market cap, valuation, profitability and leverage metrics of ECILC and CIMSA side by side.

ECILCCIMSA
StockFund

If you had invested TRY 10,000

Metric comparison

ECILC vs CIMSA Comparison
MetricECILCCIMSASector median
Last price (TL)63.6042.5218.72
Daily change−7.15%−0.65%−4.95%
Market capTRY 43.6BTRY 40.2BTRY 4.4B
P/E—9.3218.20
P/B0.681.081.14
Dividend yield2.04%1.50%0.90%
Return on equity−3.08%12.50%1.78%
Free float22.02%45.08%37.21%
Ratios are calculated from the latest published financial statements.

Popular comparisons

Related pages

About the ECILC vs CIMSA comparison

Price, market cap, valuation multiples, profitability and leverage of ECILC (Eczacıbaşı İlaç) and CIMSA (Cimsa) side by side as of Sep 28, 2026, 12:58. Of the 16 metrics compared, ECILC leads in 9 and CIMSA leads in 7.

Highlights: Daily change: CIMSA leads (−0.65% vs −7.15%). Market cap: ECILC leads (TRY 43.6B vs TRY 40.2B). P/B: ECILC leads (0.68 vs 1.08). EV/EBITDA: CIMSA leads (8.12 vs 165.19). EV/Sales: CIMSA leads (2.62 vs 9.35). Dividend yield: ECILC leads (2.04% vs 1.50%). Gross margin: ECILC leads (37.83% vs 17.56%). EBITDA margin (annual): CIMSA leads (18.96% vs 11.49%).

Frequently asked questions

By P/E, Tie is cheaper (— vs 9.32); by P/B, ECILC trades at the lower multiple (0.68 vs 1.08).

Annual net margin is −20.86% for ECILC and 9.76% for CIMSA; return on equity is −3.08% for ECILC and 12.50% for CIMSA.

The leverage ratio is 18.92 for ECILC and 52.21 for CIMSA; net debt/EBITDA is 1.37 for ECILC and 3.11 for CIMSA. Lower values mean less leverage.

Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.